Concepedia

Wayne Blosser

WB

20

Publications

1.4K

Citations

17

H-Index

2007

Active since

Affiliations

Eli Lilly (United States)(Current)

Università Cattolica del Sacro Cuore

The University of Texas MD Anderson Cancer Center

Istituto Superiore di Sanità

Wayne Blosser is an author at Eli Lilly (United States) specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

2007–2020

20

Publications

20

RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies

Benjamin Solomon, Lavinia Tan, Stephen Q. Wong et al. · Journal of Thoracic Oncology · 2020 · 272 citations · Full text

Aurora A Kinase Inhibition Is Synthetic Lethal with Loss of the <i>RB1</i> Tumor Suppressor Gene

Xueqian Gong, Jian Du, Stephen H. Parsons et al. · Cancer Discovery · 2018 · 220 citations

LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms

Constance King, H. Bruce Diaz, Samuel McNeely et al. · Molecular Cancer Therapeutics · 2015 · 183 citations · Full text

, , +18

Characterization and preclinical development of LY2603618: a selective and potent Chk1 inhibitor

Constance King, Henry Diaz, Darlene Barnard et al. · Investigational New Drugs · 2013 · 109 citations

, , +8

Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models

Caitlin D. Lowery, Michele Dowless, Matthew Renschler et al. · Clinical Cancer Research · 2018 · 79 citations · Full text

Rows per page

1–5 of 20